✦ LIBER ✦

Zotarolimus- Versus Everolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease

✍ Scribed by Mehilli, Julinda; Richardt, Gert; Valgimigli, Marco; Schulz, Stefanie; Singh, Ambika; Abdel-Wahab, Mohamed; Tiroch, Klaus; Pache, Jürgen; Hausleiter, Jörg; Byrne, Robert A.; Ott, Ilka; Ibrahim, Tareq; Fusaro, Massimiliano; Seyfarth, Melchior; Laugwitz, Karl-Ludwig; Massberg, Steffen; Kastrati, Adnan

Book ID: 122022516
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 447 KB
Volume: 62
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2013.07.044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel- Versus Sirolimus-Eluting Ste

Paclitaxel- Versus Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Disease

✍ Julinda Mehilli; Adnan Kastrati; Robert A. Byrne; Olga Bruskina; Raisuke Iijima; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 570 KB

Zotarolimus-eluting Versus Everolimus-el

Zotarolimus-eluting Versus Everolimus-eluting Stents for Treatment of Unprotected Left Main Coronary Artery Stenosis: 2-year Follow-up of Single-center Registry

✍ Im, Sung Il; Rha, Seung-Woon; Choi, Byoung Geol; Choi, Se Yeon; Kim, Sun Won; Na 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Comparison of Drug-Eluting Stents Versus

Comparison of Drug-Eluting Stents Versus Surgery for Unprotected Left Main Coronary Artery Disease

✍ Marcelo Sanmartín; José Antonio Baz; Ramon Claro; Vanesa Asorey; Darío Durán; Go 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Sirolimus-eluting stents effective for u

Sirolimus-eluting stents effective for unprotected left main coronary artery restenosis

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Everolimus-Eluting versus Paclitaxel-Elu

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

✍ Stone, Gregg W.; Rizvi, Ali; Newman, William; Mastali, Kourosh; Wang, John C.; C 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 379 KB

Everolimus-Eluting versus Paclitaxel-Elu

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

✍ Stone, Gregg W.; Rizvi, Ali; Newman, William; Mastali, Kourosh; Wang, John C.; C 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 379 KB

## Background: Previous studies have established the superiority of coronary everolimus-eluting stents over paclitaxel-eluting stents with respect to angiographic findings. however, these trials were not powered for superiority in clinical end points. ## Methods: We randomly assigned 3687 patient